46
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Implementing Analytical Quality by Design (AQbD) Approach for Simultaneous Estimation of Tadalafil and Macitentan by RP-HPLC Method

, , , , , , & show all
Pages 539-552 | Received 23 Aug 2020, Accepted 29 May 2021, Published online: 13 Jul 2021

References

  • Kathleen, P., Sweetman, S.C. (2009). Martindale The Complete Drug References (36th Edition). Pharmaceutical Press, 2468 and 1427.
  • Brunton, L. Laurence. (2011). Good man and Gilman’s The Pharmacological Basis of Therapeutics. In: Barnes P.J. Pulmonary Pharmacology. New York, The McGraw-Hill Companies. Pp. 1059-1061.
  • United States Food and Drug Administration. (2020). Clinical Trials. https://clinicaltrials.gov/ct2/show/NCT03904693?term=tadalafil+and+macitentan&cond=Pulmonary+Arterial+Hypertension&draw=2&rank=1. (accessed August 22, 2020)
  • Peraman, R., Bhadraya, K., Reddy, Y.P. (2015). Analytical Quality by Design: A Tool for Regulatory Flexibility and Robust Analytics. International Journal of Analytical Chemistry. 2015: 1-9. doi: 10.1155/2015/868727
  • ICH Harmonized Tripartite Guidelines (2008). Q10 Pharmaceutical Quality System: Text and Methodology.
  • Chatterjee, S. (2013). QbD Considerations for Analytical Methods - FDAPerspective Baltimore, 25 January 2013. Proceedings. Baltimore, Food, and Drug Administration. Pp 1-20.
  • Christine, M.V. (2012). International Conference on Drug Development, Quality by Design–FDA Lessons Learned and Challenges for International Harmonization Austin, Texas, 28 February 2012. Proceedings. Texas, Food and Drug Administration. Pp 1-28.
  • Alasandro, M., Fleitman, J., Little, T. (2013). Pharmaceutical Technology Method Validation by design to support Formulation Development. Pharmaceutical Technology. 1-5.
  • Sutar, A.S., Magduma, C.S., Patila, S.S., Naikawadia, N.S. (2008). RP-HPLC Estimation of tadalafil in tablet dosage form. International Journal of Chemical Science. 6(2): 1223-1227.
  • Sonawane, P.H., Panzade, P.S., Kale, M.A. (2013). Rapid estimation of Tadalafil by RP-HPLC method in bulk and tablet formulation. Indian Journal of Pharmaceutical Sciences. 75(2): 230-233.
  • Unnisa, A., Babu, Y., Suggu, S.K., Chaitanya, S. (2014). RP-HPLC-PDA method development and validation for the analysis of Tadalafil in bulk, pharmaceutical dosage forms and in vitro dissolution sample. Journal of Applied Pharmaceutical Science. 4(12): 072-076.
  • Yang, Y.J., Song, D.M., Jiang, W.M., Xiang B.R. (2010). Rapid Resolution RP-HPLC-DAD Method for Simultaneous Determination of Sildenafil, Vardenafil, and Tadalafil in Pharmaceutical Preparations and Counterfeit Drugs. Analytical Letters. 43(3): 373-380. doi: 10.1080/00032710903402283
  • Fraihat, S. (2014). Spectrophotometric methods for the determination of Tadalafil in pharmaceutical forms, International Journal of Pharmacy and Pharmaceutical Science. 6(7): 443-445.
  • Vyas, A.J., Gol, D.A., Patel, A.I., Patel, A.B., Patel, N.K., Chudasama, A. (2020). A stress degradation kinetic study of Tadalafil bulk and tablet dosage form by UV Spectrophotometry. Asian Journal of Pharmaceutical Analysis. 10(4):177-181. doi: 10.5958/2231-5675.2020.00032.0
  • Patel, J.K., Patel, N.K. (2014). Stability indicating RP-HPLC method for the determination of ambrisentan and Tadalafil in pharmaceutical dosage form. Sei Pharm. 82: 749-763. doi: 10.3797/scipharm.1403-22
  • Kharat, S.S., Andale, S.P., Saudagar, R.B. (2017). Development and validation of a stability indicating RP-HPLC method for analysis of Tadalafil in bulk and tablet dosage form. European Journal of Biomedical and Pharmaceutical Sciences. 4(2): 149-153.
  • Reddy, B.P., Reddy, K.A., Reddy, M.S. (2010). Validation and stability indicating RP-HPLC method for the determination of Tadalafil API in pharmaceutical Formulation. Research in Pharmaceutical Biotechnology. 2(1): 001-006.
  • Enderle, Y., Witt, L., Wilkens, H., Gruning, E., Haefeli, W.E., Burhenne, J. (2017). Simultaneous quantification of endothelin receptor antagonist and phosphodiesterase 5 inhibitor currently used in pulmonary hypertension. Journal of Pharmaceutical and Biomedical Analysis. 143(5): 291-298. doi: 10.1016/j.jpba.2017.05.052
  • Lixiu, Y., Zhou, Y., Xiaomeng, H., Huqun, L., Hui, C., Weiyong, L. (2015). Simultaneous determination of Macitentan and its active metabolite in human plasma by liquid chromatography- tandem mass spectrometry. Journal of Chromatography B. 1002: 358-363. doi: 10.1016/j.jchromb.2015.07.053
  • Abdel Hamid, M.E. (2006). Determination of Sildenafil, Tadalafil and Vardenafil in Tablets and Adulterated Herbal Products by ESI-MS-MS. Journal of Liquid Chromatography and Related Technologies. 29(4): 591-603. doi: 10.1080/10826070500479393
  • Albayrak, M., Atila, A., Ucar, A.Y., Araz, O., Kadioglu, Y. (2019). A novel, rapid and sensitive UPLC-MS/MS method for the determination of Macitentan in patients with pulmonary arterial hypertension. Biomedical Chromatography. 33: 1-8. doi: 10.1002/bmc.4502
  • Satheesh, B., Sreeganesh, K.K., Saravanan, D. (2013). Simultaneous determination of Tadalafil and its related compounds in pharmaceutical dosage forms by UPLC. Journal of Liquid Chromatography and Related Technologies. 36(10): 1451-1465. doi: 10.1080/10826076.2012.692143
  • Kim, K.Y., Nam, M., Kwon, H.J., Kim, H.Y., Kang, S.H., Kim, S.I., Kim, C.W., Cho, S.H. (2017). Validated UPLC-MS/MS method for the determination of Tadalafil in human plasma and its application to a pharmacokinetic study. Transl. Clin. Pharmacol. 25(1): 21-27.
  • Nikolaou, P., Papoutsis, I., Athanaselis, S., Alevisopoulos, G., Khraiwesh, A., Pistos, C., Spiliopoulou, C. (2011). Development and validation of a GC/MS method for the determination of Tadalafil in whole blood. Journal of Pharmaceutical and Biomedical Analysis. 56: 577-581. doi: 10.1016/j.jpba.2011.05.036
  • Anerao, A., Patil, B., Solse, V., Patil, C. (2019). Quantification of Genotoxic Impurities in Tadalafil by Simple and Sensitive Gas Chromatography Technique. Analytical Chemistry Letters. 9(4): 518-525. doi: 10.1080/22297928.2019.1652683
  • Demirel, G., Saray, D., Yaman, B., Turkyilmaz, A. (2018). Quality by Design approach for an orally disintegrating tablet analytical method validation. International Journal of Pharmaceutical Science and Drug Research. 10(1): 12-19.
  • ICH Harmonized Tripartite Guidelines (2005). Q2 (R1) Validation of Analytical Procedures: Text and Methodology.
  • ICH Harmonized Tripartite Guidelines (2005). Q9 Quality Risk Management: Text and Methodology.
  • Nuno, R.C., Lourenco, J., Zulema, L.P. (2011). Desirability function approach: A review and performance evaluation in adverse conditions. Chemometrics and Intelligent Laboratory Systems. 107: 234-244. doi: 10.1016/j.chemolab.2011.04.004

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.